Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Vladimír Šámal"'
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Patients, especially inpatients, with spinal cord lesions and disorders (SCI/D) have an elevated risk of recurrent urinary tract infections with multidrug resistant (MDR) bacteria. This study evaluated antimicrobial resistance and
Externí odkaz:
https://doaj.org/article/9385d606eb844b4893ae49a08d16d605
Publikováno v:
Diagnostic Pathology, Vol 17, Iss 1, Pp 1-6 (2022)
Abstract Background Yolk sac tumor (YST) is a germ cell tumor. It is primarily located in the gonads but can also occur extragonadally (extragonadal yolk sac tumor - EGYST), most commonly in the pelvis, retroperitoneum or mediastinum. Only a few YSTs
Externí odkaz:
https://doaj.org/article/b8c655197dbe4bf48a77ccd5f08905a5
Publikováno v:
International Neurourology Journal, Vol 24, Iss 1, Pp 59-65 (2020)
Purpose To evaluate intravesical loss of onabolunumtoxinA (onaBTA) during endoscopic injection into the bladder wall for treatment of neurogenic detrusor overactivity (NDO). The intraluminal loss of onaBTA cannot be determined directly, therefore we
Externí odkaz:
https://doaj.org/article/8ecabf904a174f1599aedf069b9e4a00
Publikováno v:
Onkologie. 17:119-122
Publikováno v:
Onkologie. 17:26-30
Publikováno v:
Onkologie. 16:322-325
Publikováno v:
Spinal Cord. 60:733-738
Retrospective cohort study.The aim of this study was to assess the time to first detection of multidrug-resistant bacteria (MDRB) in urine culture and identify risk factors associated with the first detection of MDRB (1Spinal Care Ward and Department
Autor:
Igor Richter, Alexandr Poprach, Anežka Zemánková, Tomáš Büchler, Jiří Bartoš, Vladimír Šámal, Hana Študentová, Aneta Rozsypalová, Josef Dvořák, Ondřej Brom, Bohuslav Melichar
Publikováno v:
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti. 34(5)
Current standard treatments for patients with metastatic renal cell carcinoma (mRCC) involve tyrosine kinase inhibitors (TKI) that inhibit angiogenesis. Cabozantinib is a multi TKI used for the treatment of mRCC in the first- and second-line setting.
Background Patients, especially inpatients, with spinal cord lesions and disorders (SCI/D) have an elevated risk of recurrent urinary tract infections with multidrug resistant (MDR) bacteria. This study evaluated antimicrobial resistance and the prev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::34e411a7bbc5f288a41342062b8d65d4
https://doi.org/10.21203/rs.3.rs-1046860/v1
https://doi.org/10.21203/rs.3.rs-1046860/v1
Publikováno v:
International Neurourology Journal
International Neurourology Journal, Vol 24, Iss 1, Pp 59-65 (2020)
International Neurourology Journal, Vol 24, Iss 1, Pp 59-65 (2020)
Purpose: To evaluate intravesical loss of onabolunumtoxinA (onaBTA) during endoscopic injection into the bladder wall for treatment of neurogenic detrusor overactivity (NDO). The intraluminal loss of onaBTA cannot be determined directly, therefore we